Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Quality exists only to the extent that individual manufacturers choose to maintain it, and not all of them choose well
When this synthetic peptide is injected into the body, the result could vary from individual to individual
Important: You cannot prime without a needle because the check requires medicine to pass through the needle tip
About the HRS9531-301 Clinical Trial The HRS9531-301 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m2) or overweight (BMI 24 kg/m2) and at least one weight-related comorbidity without diabetes
Woodfield GW, Horan AD, Chen Y, Weigel RJ
most cardiovascular outcome trials excluded patients with end-stage renal disease (ESRD) or those receiving maintenance dialysis
US$ 27.96
US$ 28.28
US$ 29.73
US$ 23.91
